Modalis Therapeutics Corporation Logo

Modalis Therapeutics Corporation

Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.

4883 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋本町三丁目11番5号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Modalis Therapeutics Corporation is a biotechnology company that pioneers the development of therapeutics for genetic diseases through epigenome editing. The company's proprietary core platform, CRISPR-GNDM®, is an advanced technology designed to regulate gene expression by selectively activating or suppressing specific genes without altering the underlying DNA sequence. This system utilizes a compact editor that can be delivered to target cells via AAV vectors. Modalis operates a hybrid business model, advancing therapeutic candidates through both in-house development pipelines for subsequent licensing and collaborative partnerships. Its development pipeline is focused on addressing unmet medical needs in muscular disorders, cardiomyopathy, and central nervous system (CNS) disorders.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:48
Registration Form
訂正有価証券届出書(組込方式)
Japanese 237.5 KB
2025-08-14 08:31
Regulatory News Service
確認書
Japanese 8.9 KB
2025-08-14 08:30
Interim Report
半期報告書-第10期(2025/01/01-2025/12/31)
Japanese 266.6 KB
2025-08-07 08:32
Registration Form
有価証券届出書(組込方式)
Japanese 334.6 KB
2025-03-28 07:52
Post-Annual General Meeting Information
臨時報告書
Japanese 28.4 KB
2025-03-27 08:32
Regulatory News Service
内部統制報告書-第9期(2024/01/01-2024/12/31)
Japanese 24.1 KB
2025-03-27 08:30
Regulatory News Service
確認書
Japanese 8.7 KB
2025-03-27 08:29
Annual Report
有価証券報告書-第9期(2024/01/01-2024/12/31)
Japanese 2.1 MB
2025-02-21 07:31
Audit Report / Information
臨時報告書
Japanese 21.5 KB
2024-08-13 08:14
Registration Form
訂正有価証券届出書(組込方式)
Japanese 293.9 KB
2024-08-13 07:58
Interim Report
半期報告書-第9期(2024/01/01-2024/12/31)
Japanese 249.6 KB
2024-08-13 07:58
Registration Form
確認書
Japanese 8.9 KB
2024-08-07 08:01
Registration Form
有価証券届出書(組込方式)
Japanese 495.2 KB
2024-05-14 06:00
Quarterly Report
四半期報告書-第9期第1四半期(2024/01/01-2024/03/31)
Japanese 166.1 KB
2024-05-14 06:00
Report Publication Announcement
確認書
Japanese 8.9 KB

Automate Your Workflow. Get a real-time feed of all Modalis Therapeutics Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Modalis Therapeutics Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.